Home Blog Page 885

YY Group Welcomes The Landmark Bangkok to Growing Hospitality Client Portfolio

New Manpower Outsourcing Contract Advances Subsidiary YY Circle Thailand’s Path to Meaningful Scale, Adds to 2026 Revenue Visibility

SINGAPORE, March 13, 2026 /PRNewswire/ — YY Group Holding Limited (NASDAQ: YYGH) (“YY Group” or the “Company”), a global leader in on-demand workforce solutions and integrated facilities management (IFM), today announced that its Thailand subsidiary, YY Circle (Thailand) Co., Ltd. (“YY Circle Thailand”), has signed a one-year manpower outsourcing contract with The Landmark Bangkok, one of Thailand’s most prominent luxury hotels. The agreement further strengthens YY Circle Thailand’s growing portfolio of premium hospitality clients and advances the Company’s strategy to build Thailand into its next significant manpower revenue contributor alongside its subsidiaries in Singapore, Hong Kong, and Malaysia.

Since joining YY Group in June 2025, YY Circle Thailand has rapidly built a portfolio of internationally recognized hotel clients, including Central Group, CP All, Shangri-La, Banyan Tree, Hyatt, Sheraton, and JW Marriott. The five-star Landmark Bangkok further extends the Company’s reach within Thailand’s luxury hospitality segment and increases the density of its client base in the Bangkok metropolitan area, driving greater operational efficiency and workforce utilization. The addition of this iconic property to YY Circle Thailand’s client roster also reinforces the Company’s reputation as a trusted workforce partner to the highest tier of Bangkok’s hospitality market.

Mike Fu, Chief Executive Officer and Executive Director of YY Group Holding Limited, commented, “Winning The Landmark Bangkok represents another important step in our Thailand growth story. Each new partnership with a world-class hotel property strengthens our operational footprint, deepens our talent pool, and moves us closer to reaching the operational density needed to achieve scale in the Thai market. Thailand represents one of the most compelling hospitality workforce opportunities in Southeast Asia, and our continued investment in regional capacity and operational infrastructure is enabling us to capture these opportunities at an accelerating pace. We are confident that YY Circle Thailand is on a clear trajectory to join our Singapore, Hong Kong, and Malaysia subsidiaries as a core growth engine for our manpower segment.”

Jirapat Haetanurak, Co-founder and Country Director of YY Circle Thailand, added, “The Landmark Bangkok is one of Thailand’s most iconic hotels and a property we are proud to serve. This win reflects premier hospitality operators’ growing confidence in our people, our technology-enabled staffing model, and our ability to deliver consistent service quality at scale. With each new client, we are building the operational presence needed to make Thailand a major market for YY Group, and we see significant runway ahead.”

This client win strengthens YY Group’s position in Thailand’s premium hospitality workforce market, where rising international tourism and increasing demand for flexible, compliant manpower solutions continue to create attractive growth opportunities. The Company will continue pursuing partnerships with leading hotel brands as part of its broader strategy to scale its Thailand operations and build long-term recurring revenue streams in one of Southeast Asia’s most dynamic markets.

About YY Group Holding Limited

YY Group Holding Limited (Nasdaq: YYGH) is a Singapore-headquartered, technology-enabled platform providing flexible, scalable workforce solutions and integrated facility management (IFM) services across Asia and beyond. The Group operates through two core verticals: on-demand staffing and IFM, delivering agile, reliable support to industries such as hospitality, logistics, retail, and healthcare.

Leveraging proprietary digital platforms and IoT-driven systems, YY Group enables clients to meet fluctuating labor demands and maintain high-performance environments. In addition to its core operations in Singapore and Malaysia, the Group maintains a growing presence in Asia, Europe, Africa, Oceania and the Middle East.

Listed on the Nasdaq Capital Market, YY Group is committed to service excellence, operational innovation, and long-term value creation for clients and shareholders.

For more information on the Company, please visit https://yygroupholding.com/.

Safe Harbor Statement

This press release contains forward-looking statements. These statements are made under the “safe harbor” provisions of the U.S. Private Securities Litigation Reform Act of 1995. Statements that are not historical facts, including statements about the YY Group Holding Limited’s beliefs and expectations, are forward-looking statements. Forward-looking statements involve inherent risks and uncertainties, and a number of factors could cause actual results to differ materially from those contained in any forward-looking statement. These factors include, but are not limited to, (i) growth of the hospitality market (ii) capital and credit market volatility, (iii) local and global economic conditions, (iv) our anticipated growth strategies, (v) governmental approvals and regulations, and (vi) our future business development, results of operations and financial condition. In some cases, forward-looking statements can be identified by words or phrases such as “may,” “will,” “expect,” “anticipate,” “target,” “aim,” “estimate,” “intend,” “plan,” “believe,” “potential,” “continue,” “is/are likely to” or other similar expressions. All information provided in this press release is as of the date of this press release, and YY Group Holding Limited undertakes no duty to update such information, except as required under applicable law.

Investor Contact
Jason Phua Zhi Yong, Chief Financial Officer
YY Group
enquiries@yygroupholding.com

 

ThunderSoft Showcases Edge AI Innovations at embedded world 2026, Highlighting the Rise of Intelligent Edge Systems

NUREMBERG, Germany, March 13, 2026 /PRNewswire/ — As embedded world 2026 concludes in Nuremberg, one theme stands out across the exhibition halls: the rapid acceleration of intelligent edge systems. With the convergence of high-performance computing, on-device AI, and industry-specific software platforms, enterprises are increasingly shifting intelligence from the cloud to the edge to enable real-time decision-making, improved efficiency, and scalable deployment across industrial and robotic environments.

Against this backdrop, ThunderSoft, together with its joint venture Thundercomm, showcased a series of innovations designed to accelerate edge intelligence across industries. During the event, Thundercomm introduced three new solutions that demonstrate how advanced hardware platforms and software stacks are enabling a new generation of edge AI applications.

Thundercomm at embedded world 2026
Thundercomm at embedded world 2026

TurboX IRB10 Development Kit for Physical AI and Robotics
Built on the Qualcomm Dragonwing™ IQ10 series, the TurboX IRB10 development board and reference design targets emerging Physical AI applications such as autonomous mobile robots (AMRs) and humanoid robots. The platform provides high-performance heterogeneous computing, AI acceleration, and rich sensor connectivity, enabling developers to rapidly prototype and scale intelligent robotics systems for industrial and service environments.

Edge AI–Powered Industrial Inspection Solution
Thundercomm also demonstrated an intelligent industrial inspection solution developed in collaboration with ecosystem partners. By combining edge AI inference with machine vision technologies, the solution enables real-time defect detection directly on the factory floor. This approach significantly reduces reliance on manual inspection and cloud processing, improving manufacturing quality control while lowering operational costs and latency.

TurboX EB8 Edge Intelligence Computing Device
Complementing these solutions is the TurboX EB8, a compact edge computing device designed for AI workloads in industrial and enterprise environments. The system integrates high-performance compute, flexible I/O, and robust software support to enable deployment of vision analytics, intelligent automation, and edge-based AI services across a wide range of real-world scenarios.

Together, these three innovations illustrate a broader industry transition: the emergence of scalable edge intelligence platforms that connect powerful computing, AI capabilities, and industry software frameworks. From robotics to smart manufacturing, edge AI is rapidly becoming the backbone of next-generation intelligent systems.

ThunderSoft’s presence at embedded world reflects its long-term commitment to enabling this transformation. With deep expertise in operating systems, AI frameworks, edge computing, and industry software platforms, ThunderSoft provides end-to-end technologies that help enterprises bring intelligent products and solutions to market faster.

As industries accelerate their adoption of edge AI, ThunderSoft continues to work closely with global technology partners and ecosystem developers to unlock new possibilities for intelligent devices, connected systems, and AI-driven industrial innovation.

About ThunderSoft
ThunderSoft, a world-leading provider of operating systems and on-device AI products and technologies, has been continuously accumulating and innovating in the operating system field, with its business expanding gradually from smart phone to smart vehicle, AIoT and smart industries. ThunderSoft was successfully listed in 2015, which leads it to be China’s very first listed technical company specialized in the intelligent operating system. ThunderSoft now operates in more than 40 cities worldwide and has over 15,000 employees, with over 90% of them focused on R&D. Further information available at: https://en.thundersoft.com

Unixell Biotech receives IND clearance by FDA for its Allogeneic iPSC-Derived cell therapy, UX-GIP001, for focal Epilepsy

SHANGHAI, March 13, 2026 /PRNewswire/ — On March 12, Unixell Biotech achieved a significant milestone as UX-GIP001, its iPSC-derived allogeneic cell therapy targeting focal epilepsy, secured Investigational New Drug (IND) clearance from the U.S. Food and Drug Administration (FDA). This breakthrough marks UX-GIP001 as the first iPSC-derived allogeneic epilepsy cell therapy approved in the U.S. and simultaneously establishes it as China’s pioneering cell therapy for epilepsy to advance into the clinical stage.

Epilepsy is a common neurological disorder affecting over 70 million people worldwide. It is prevalent in infants and the elderly, and can be triggered by events like brain injury or surgical trauma. While resection and neurostimulation help some, they have significant side effects, so innovative therapies are urgently needed to selectively target epileptic foci while preserving healthy tissue and avoiding drug effects.

In epilepsy patients, impaired GABAergic interneurons drive neural hyperexcitability and seizures. UX-GIP001 targets this by leveraging Unixell’s proprietary stem cell technology to produce inhibitory neural progenitor cells through directed differentiation. After transplantation, it reconstructs inhibitory circuits, suppressing seizures. The preclinical studies have demonstrated the efficacy of UX-GIP001 in epileptic animal models and its safety profile, supporting progression to clinical trials. Phase 1 study is planned to evaluate the safety, tolerability, and efficacy of UX-GIP001 for drug-resistant epilepsy patients.

With UX-GIP001 advancing into the clinical stage, Unixell Biotech has established a core product pipeline targeting Parkinson’s disease and epilepsy—two areas burdened by significant unmet clinical needs. The company is simultaneously advancing both autologous and allogeneic cellular therapy strategies, building a comprehensive product matrix that spans diverse indications and treatment scenarios. Leveraging its internationally leading human pluripotent stem cell R&D platform and sophisticated neural cell directed differentiation technology, Unixell Biotech is continuously expanding its capabilities to develop and translate cellular drugs for multiple indications. Driven by scientific evidence, the company is dedicated to building a long-term competitive, innovative cellular therapy platform, striving to deliver safer and more effective breakthrough treatment options for patients worldwide!

About UniXell Biotech
Shanghai UniXell Biotechnology Co., Ltd. was established in 2021, specializing in the research and development of cell therapy drugs for neurological diseases, including Parkinson’s disease and epilepsy.

The company is equipped with a 4,000-square-meter R&D center and GMP facilities. It has developed four major innovative technology platforms based on reprogramming technology, stem cell differentiation technology, SISBAR lineage tracing technology, and high-precision gene editing. These platforms facilitate the development and production of neural cell drugs with higher purity and more stable efficacy, ensuring efficient and safe clinical treatment outcomes. As of the present, UniXell has successfully obtained several rounds of financing from esteemed investors, such as Hillhouse Capital, CDH Investments, Fosun Group, Sherpa Healthcare Partners, TF Capital and Tasly Capital, among others. This underscores the robust market confidence in its pioneering therapeutic solutions and its potential for growth.

Contact
UniXell Biotechnology Co., Ltd.
business@unixell.com 

XtalPi Holdings Limited to Announce 2025 Annual Results on March 25, 2026

CAMBRIDGE, Mass., March 13, 2026 /PRNewswire/ — XtalPi Holdings Limited (“XtalPi”, or the “Company”) (HKEX: 2228), a leading global technology company in integrating artificial intelligence (AI) and robotics for drug and materials discovery, announced that it will report its annual results for the full year ended December 31, 2025 on Wednesday, March 25, 2026, after the Hong Kong market closes.

The Company will hold a conference call in Chinese with English simultaneous interpretation at 7:00 PM Hong Kong/Beijing Time on March 25, 2026 (7:00 AM U.S. Eastern Time on the same day). Details for the conference call are as follows:

For Chinese original audio channel:

Online Registration Link: https://s.comein.cn/cwi78hst

Alternatively, participants may access the conference call by dialing the following numbers:

Mainland China:

+86-4001510269

International:

+86-1021377168

Hong Kong, China:

+852-51089680

Taiwan, China:

+886-277083288

United States:

+1-2087016888

Password:

040763

The replay of the conference call will be available on the Company’s investor relations website at https://ir.xtalpi.com/en/investor-relations.

For English simultaneous interpretation channel:

Online Registration Link: https://s.comein.cn/7jmvczxy

About XtalPi

XtalPi Holdings Limited (XtalPi, 2228.HK) was founded in 2015 by three physicists from the Massachusetts Institute of Technology (MIT). It is an innovative R&D platform powered by quantum physics, artificial intelligence, and robotics. By integrating first-principles calculations, AI algorithms, high-performance cloud computing, and standardized automation systems, XtalPi provides digital and intelligent R&D solutions for companies in the pharmaceutical, materials science, agricultural technology, energy, new chemicals, and cosmetics industries.

Investor Relations Contact:

In China:

XtalPi Holdings Limited
Investor Relations
Email: ir@xtalpi.com

Piacente Financial Communications
Tel: +86-10-6508-0677
Email: XtalPi@thepiacentegroup.com

In the United States:

Piacente Financial Communications
Brandi Piacente
Tel: +1-212-481-2050
Email: XtalPi@thepiacentegroup.com

OPPO and Google Partner to Redefine Productivity for Foldable Devices with Next-Gen AI Stylus Experience


SHENZHEN, CHINA – Media OutReach Newswire – 13 March 2026 – OPPO, a leading global smart device brand, is deepening its collaboration with Google Cloud to reimagine AI-powered productivity on its upcoming Find N6 foldable flagship with the new OPPO AI Pen.

OPPO AI Pen Kit_Front.jpg

Kai Tang, President of Software Engineering at OPPO, said: “OPPO’s close collaboration with partners like Google Cloud enables us to bring the latest and most advanced AI experiences to our users. Featuring powerful AI capabilities, we have evolved the traditional stylus into the innovative OPPO AI Pen, marking a significant leap in efficiency for the foldable smartphone experience.”

AI Chart and AI Image: Next-Level Productivity with OPPO AI Pen

The upcoming Find N6 will launch together with the OPPO AI Pen, featuring exclusive AI Chart and AI Image functions built with Google Cloud’s cutting-edge AI capabilities.

While taking notes or sketching ideas with a stylus helps capture inspiration quickly, translating handwritten drafts into polished, professional formats has always been a challenge. With AI Chart built with Gemini Pro, users can press the dedicated side button on the OPPO AI Pen and simply circle their handwritten notes to instantly generate a clean, editable digital table, allowing for faster information organization in meetings, planning sessions, and daily work.

Beyond text and charts, the AI Image feature is built with Nano Banana, and further expands creative possibilities by transforming simple doodles into refined artwork. Users can even provide specific text prompts to guide the AI, reimagining their drawings in any style, from classic oil painting textures to modern digital art.

Enhanced Cross-Ecosystem Sharing

OPPO is also collaborating with Google to bring AndroidTM Quick Share compatibility with Apple devices to Find N6. In the coming weeks, users will be able to send photos, videos, and files directly to Apple devices—with no additional apps required, advancing cross-ecosystem connection.

Next-Level Productivity on Find N6

These advanced productivity-enhancing features of ColorOS 16 will be fully integrated into the upcoming OPPO Find N6, delivering a high-performance and seamless experience from the very first touch. By combining OPPO’s advanced hardware with Google’s AI capabilities, Find N6 is set to turn the foldable device into a true mobile workstation, empowering users to create, collaborate, and communicate like never before.

Disclaimer: AI Chart is built with Gemini 2.5 Pro, while AI Image is built with Nano Banana (Gemini 2.5 Flash Image).

*Google, Android and Quick Share are trademarks of Google LLC.

Hashtag: #OPPO

The issuer is solely responsible for the content of this announcement.

POMDOCTOR LIMITED Announces Strategic Upgrade, Focusing on “AI + Medical-Grade Smart Wearables” to Build a New Ecosystem for Full-Cycle Chronic Disease Management

GUANGZHOU, China, March 13, 2026 /PRNewswire/ — Pomdoctor Limited (“Pomdoctor” or the “Company”) (NASDAQ: POM), a leading online medical services platform for chronic diseases in China, today announced a strategic upgrade centered on the core track of “artificial intelligence (“AI”) + medical-grade smart wearables + full-cycle chronic disease management”.

The Company plans to accelerate related technology research and development (“R&D”) and scenario-based implementation by leveraging its extensive medical resources and strong compliance capabilities. Over the long run, Pomdoctor aims to build a closed-loop chronic disease management ecosystem integrating hardware, data, algorithms and services, expanding the Company’s long-term growth horizon while delivering sustained medical value to patients.

According to Global Market Insights, the global chronic disease management market was valued at USD 6.2 billion in 2024 and is projected to grow from USD 6.9 billion in 2025 to USD 18.8 billion by 2034, representing a compound annual growth rate (CAGR) of 11.7%. In China, driven by an aging population and approximately 180 million people living with chronic conditions, the country has emerged as one of the world’s largest and most promising markets for chronic disease management technologies and services.

Against this backdrop, traditional outpatient-based chronic disease management continues to face structural challenges, including fragmented monitoring, delayed medical intervention, and low patient adherence. The broader adoption of smart wearable technologies and emerging AI applications is now beginning to reshape the landscape, pointing toward a new paradigm for digital healthcare.

According to Pomdoctor, this strategic upgrade represents a natural extension of the Company’s longstanding expertise and operational experience in chronic disease management, rather than a cross-industry expansion without prior validation. All R&D and commercialization activities will strictly comply with applicable medical regulatory requirements in both China and the United States, with evidence-based medicine serving as the foundational principle.

The strategic upgrade will focus on three core areas of compliant implementation:

  • Developing a portfolio of medical-grade smart wearable devices capable of delivering accurate and continuous physiological data to support chronic disease management, particularly for high-prevalence conditions such as diabetes and cardiovascular diseases;
  • Building an AI-powered intelligent chronic disease management system. Leveraging health data collected from wearable devices and grounded in established clinical treatment guidelines, the system is designed to function as an intelligent assistant for risk monitoring, treatment plan support, and doctor-patient collaboration, ultimately improving management efficiency and patient adherence to outpatient care;
  • Establishing a closed-loop chronic disease management service system that integrates hardware terminals and AI systems with the Company’s existing internet hospital platform, pharmaceutical supply chain, and chronic disease service infrastructure, enabling full-cycle services from monitoring and early warning to intervention and follow-up.

The Company plans to support this strategic transformation through three core competitive advantages:

  • A strong medical compliance foundation: established internet hospital qualifications, a nationwide network of licensed physicians, and a comprehensive compliance management system supported by deep understanding of clinical needs and regulatory frameworks;
  • Collaborative R&D capabilities: a multidisciplinary team of algorithm experts, hardware engineers, and clinical medicine specialists to ensure close alignment between technological innovation and real-world clinical requirements;
  • Advantages as a U.S.-listed company: a standardized corporate governance structure, global resource integration capabilities, and stable capital access to support technology R&D, clinical validation, and international commercialization.

Mr. Zhenyang Shi, Chairman and Chief Executive Officer of Pomdoctor, commented: “The integration of AI and medical-grade wearable technologies is reshaping the paradigm of chronic disease management. Through this strategic upgrade, we will steadily advance technology R&D and real-world implementation to develop clinically meaningful chronic disease management solutions. This strategic direction reflects our unwavering commitment to medical compliance and patient-centered care. We believe this transformation aligns with the long-term evolution of the healthcare industry and will generate sustainable value for both patients and our shareholders.”

About POMDOCTOR LIMITED

POMDOCTOR LIMITED is a leading online medical services platform for chronic diseases in China, ranking sixth on China’s Internet hospital market based on the number of contracted doctors in 2022, according to Frost & Sullivan. Focusing on chronic disease management and pharmaceutical services, the Company offers a one-stop platform for medical services, organically connecting patients with doctors and pharmaceutical products. The Company’s operations primarily include Internet hospital and pharmaceutical supply chain, connecting users, pharmacies, suppliers, medical professionals, and other healthcare participants. Through this model, POMDOCTOR aims to enhance the efficiency and transparency of the healthcare value chain. The Company’s mission is to provide effective prevention and treatment solutions to alleviate patients’ sufferings from illnesses. Its vision is to become the most trustworthy medical and healthcare services platform. For more information, please visit the Company’s website: http://ir.7shiliu.com.

Forward-Looking Statements

Certain statements in this announcement are forward-looking statements. These forward-looking statements involve known and unknown risks and uncertainties and are based on the Company’s current expectations and projections about future events that the Company believes may affect its financial condition, results of operations, business strategy and financial needs. Investors can find many (but not all) of these statements by the use of words such as “approximates,” “believes,” “hopes,” “expects,” “anticipates,” “estimates,” “projects,” “intends,” “plans,” “will,” “would,” “should,” “could,” “may” or other similar expressions. The Company undertakes no obligation to update or revise publicly any forward-looking statements to reflect subsequent occurring events or circumstances, or changes in its expectations, except as may be required by law. Although the Company believes that the expectations expressed in these forward-looking statements are reasonable, it cannot assure you that such expectations will turn out to be correct, and the Company cautions investors that actual results may differ materially from the anticipated results and encourages investors to review other factors that may affect its future results in the Company’s filings with the SEC.

For more information, please contact:

POMDOCTOR LIMITED
Investor Relations Department
Email: ir@7lk.com

Ascent Investor Relations LLC
Tina Xiao
Phone: +1-646-932-7242
Email: investors@ascent-ir.com

YEEDI Launches M16 Infinity, an Award-Winning Robot Vacuum Built on the Success of the M14 PLUS

SAN FRANCISCO, March 13, 2026 /PRNewswire/ — YEEDI today announced the launch of the M16 Infinity, a next-generation robot vacuum designed to deliver stronger cleaning performance, quieter operation, and easier maintenance.

M16 Infinity
M16 Infinity

The launch builds on the success of the YEEDI M14 PLUS, a model widely recognized by both reviewers and consumers. The M14 PLUS received strong rankings in independent testing from Vacuum Wars and was also named a Top 5 pick in the Best Robot Vacuum category in the Scary Mommy 2026 Readers’ Choice Awards, highlighting its popularity among everyday households.

Building on that momentum, the M16 Infinity introduces meaningful upgrades to further enhance everyday cleaning performance. Recently named Gold Winner for Innovation in Affordable Cleaning Technology at the CES 2026, the robot continues YEEDI’s philosophy of Accessible Innovation.

“Consumers today want technology that genuinely improves everyday living,” said YEEDI. “With the M16 Infinity, we focused on refining what matters most in everyday cleaning — stronger suction, quieter operation, and a smarter roller mopping system that keeps floors consistently clean with minimal effort.”

Meaningful Upgrades from the M14 PLUS

Building on the strengths of the M14 PLUS, the M16 Infinity introduces several key upgrades to further enhance everyday cleaning performance.

At the center of the upgrade is OZMO Roller 3.0, YEEDI’s advanced roller-based mopping system. The roller mop is 50% longer than the previous generation and features pressurized self-washing technology that continuously refreshes the mop with clean water during operation. This helps prevent dirty water from spreading across floors while delivering deeper and more consistent cleaning.

The M16 Infinity also delivers a significantly quieter cleaning experience. Through redesigned airflow channels, improved motor engineering, and structural optimization, the robot achieves up to 68% lower perceived noise levels compared with the M14 PLUS, allowing it to clean comfortably in the background during work calls, daily routines, or relaxation.

The robot also delivers 30,000Pa suction power, supported by YEEDI’s BLAST airflow system for strong debris pickup across both hard floors and carpets.

Additional refinements include ZeroTangle 4.0 anti-tangle technology, enhanced edge cleaning with TrueEdge sensors, and improved obstacle detection powered by AIVI 3D 4.0. The M16 Infinity also introduces a side brush lifting mechanism, while increasing mop lifting to 15mm and barrier crossing ability to 24mm, helping the robot move smoothly between different floor types and obstacles.

Together, these improvements allow the M16 Infinity to clean more efficiently while requiring less manual maintenance.

Smarter Automation and Faster Charging

The M16 Infinity introduces several technologies designed to make automated cleaning more seamless and efficient.

Among them is PowerBoost Charging, powered by advanced gallium nitride technology. The system can recharge up to 10% of the battery in just three minutes, allowing the robot to quickly resume cleaning when it returns to the base station for self-cleaning or water replenishment.

The robot is also built for the modern smart home ecosystem. With Matter support, the M16 Infinity integrates with major voice platforms including Amazon Alexa, Google Assistant, Apple Siri Shortcuts, and Yandex Alice, allowing users to start cleaning or schedule routines using simple voice commands.

Designed for Modern Homes

As homes increasingly serve as spaces for work, family life, and relaxation, quiet and low-maintenance cleaning has become essential.

With its refined minimalist design, soft white finish, and rose-gold accents, the M16 Infinity was created to blend naturally into contemporary interiors. Subtle fabric-inspired textures and softly rounded surfaces give the robot a warmer, more refined appearance, allowing it to complement modern home décor while maintaining a calm, understated presence within the living space.

M16 Infinity
M16 Infinity

The balance of powerful performance, quiet operation, and thoughtful design makes the M16 Infinity particularly appealing for users who value both a clean home and a comfortable, well-curated living environment.

Availability

The YEEDI M16 Infinity is available starting March 13, 2026 through YEEDI’s official store. The robot vacuum carries an MSRP of $999.99 and will be offered at a limited-time introductory price of $599.99 through March 31.

About YEEDI

YEEDI is a home cleaning technology brand dedicated to making advanced robotic vacuum technology practical, reliable, and accessible for everyday households. Guided by its philosophy of Accessible Innovation, YEEDI focuses on delivering powerful, user-friendly cleaning solutions that prioritize real-world usability, low maintenance, and long-term value.

Laos Orders Nationwide Fuel Inspections Amid Hoarding Concerns

Lao State Fuel Company station at Sengsawang village, Xaysettha dsitrict, Vientiane Capital, Laos.

The Ministry of Industry and Commerce has ordered authorities across Laos to inspect fuel supplies at gas stations and storage depots, following concerns about unstable distribution and possible stockpiling.

An official notice issued on 13 March instructed provincial and district offices to carry out inspections at facilities operated by fuel importers and domestic distributors nationwide.

The move comes after a turbulent two weeks for fuel supply in Laos.

Tensions in the Middle East, which accounts for over 25 percent of global oil production, disrupted supply chains worldwide from late February, with Laos among the affected countries. Since Laos imports over 97 percent of its fuel from Thailand, the country was particularly exposed.

Between 4 and 10 March alone, diesel prices surged nearly 50 percent, from LAK 21,930 (USD 1.03) to LAK 32,860 (USD 1.54) per liter, while special gasoline recorded the second-highest price increase globally during the same period, according to Global Petrol Prices.

Some Relief Amidst Uncertainty

Thailand initially suspended fuel exports following the outbreak of the crisis but granted Laos an exemption, allowing imports to continue. Some stations experienced temporary shortages, which authorities attributed to transportation delays from storage depots rather than an overall supply deficit. On 12 March, the government announced a modest price reduction across all fuel types, with diesel falling to LAK 31,560 (USD 1.46) per liter.

The inspections are the latest step in the government’s response.

Officials will check fuel levels at depots and stations, particularly those that have recently closed or stopped service, and monitor operators for any irregular activity. 

If a station has genuinely run out of fuel, inspectors must review supply contracts with providers and examine delivery and sales records dating back to 1 February to determine whether shortages stem from the station itself or from distribution companies.

Authorities will also verify that gas station operating hours match the schedules displayed publicly at each location.

Companies or stations found violating regulations face formal warnings, suspension of operating licenses, or public disclosure as fuel hoarders.

The ministry has encouraged the public to report suspicious fuel supply activity to support monitoring efforts and maintain stable distribution across the country.